Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Guardant360
MedTech
Guardant360-guided breast cancer therapy swaps boost survival
A new study suggests using the Guardant360 CDx test to inform a treatment change could slash the risk of breast cancer progression or death by half.
Andrea Park
Jun 3, 2025 10:00am
Guardant, Merck KGaA expand precision oncology collab
Aug 31, 2022 11:56am
FDA approves Guardant's next-gen, tumor-sequencing blood test
Aug 10, 2020 8:15am
Guardant blood test tracks MSI on par with tissue biopsy: study
Aug 5, 2019 9:30am
Resolution assay beats Guardant360 in complex gene fusion study
Apr 1, 2019 11:48am
Blood tester Guardant Health files for IPO
Sep 6, 2018 12:31pm
